Abstract
Flow cytometric T-cell receptor V β repertoire analysis (TCR-V β-R) is a sensitive method to detect T-cell clonality; however, its implementation in low-cellularity specimens has not been established. We developed a strategy to use TCR-V βR in cerebrospinal fluid (CSF) and fine-needle aspirate (FNA) specimens. Initially, full TCR-V β-R was evaluated in diagnostic/ screening specimens from 8 patients with T-cell neoplasia to determine tumor-specific TCR-V β protein expression. Subsequently, an abbreviated, patientspecific TCR-V β-R evaluation was performed in 17 paucicellular specimens from the patients (8 CSF, 9 FNA) for staging and monitoring of minimal residual disease (MRD). A single cocktail containing 3 anti-V β antibodies (1 tumor-specific and 2 negative controls) in combination with other antibodies chosen to help gate on atypical T cells is highly sensitive and specific for detecting low-level neoplastic T-cell involvement in paucicellular specimens. This TCR-V β-R strategy is valuable in staging and evaluating MRD in patients with T-cell non-Hodgkin lymphoma.
Original language | English (US) |
---|---|
Pages (from-to) | 220-226 |
Number of pages | 7 |
Journal | American Journal of Clinical Pathology |
Volume | 137 |
Issue number | 2 |
DOIs | |
State | Published - Feb 2012 |
Keywords
- Cerebrospinal fluid
- Fine-needle aspirate
- Flow cytometry
- T-cell clonality
- V repertoire
ASJC Scopus subject areas
- Pathology and Forensic Medicine